These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21777284)

  • 1. Use of acid suppressive therapy more than 10 years after the endoscopic diagnosis of reflux esophagitis with specific emphasis to trademark and generic proton pump inhibitors.
    Dackus GH; Loffeld SM; Loffeld RJ
    J Gastroenterol Hepatol; 2012 Feb; 27(2):368-71. PubMed ID: 21777284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints.
    Loffeld SM; Dackus GM; Loffeld RJ
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1122-6. PubMed ID: 21934510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit of reflux oesophagitis at 4 years.
    Pace F; Bollani S; Manzionna G; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for resistance to proton pump inhibitor maintenance therapy for reflux esophagitis in Japanese women over 60 years.
    Watanabe A; Iwakiri R; Yamaguchi D; Higuchi T; Tsuruoka N; Miyahara K; Akutagawa K; Sakata Y; Fujise T; Oda Y; Shimoda R; Sakata H; Fujimoto K
    Digestion; 2012; 86(4):323-8. PubMed ID: 23128344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
    Gerson LB; Bonafede M; Princic N; Gregory C; Farr A; Balu S
    Aliment Pharmacol Ther; 2011 Sep; 34(5):555-67. PubMed ID: 21714794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
    Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
    Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflux complaints, symptom score and the use of medication in patients with reflux esophagitis: results of a long term follow-up study.
    Loffeld RJ
    Can J Gastroenterol; 2001 Aug; 15(8):505-8. PubMed ID: 11544533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis.
    Tanabe T; Hoshino S; Kawami N; Hoshikawa Y; Hanada Y; Takenouchi N; Goto O; Kaise M; Iwakiri K
    Esophagus; 2019 Oct; 16(4):377-381. PubMed ID: 31119492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of reflux esophagitis among the Chinese.
    Chang CS; Poon SK; Lien HC; Chen GH
    Am J Gastroenterol; 1997 Apr; 92(4):668-71. PubMed ID: 9128320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor.
    Kinoshita Y; Ashida K; Miwa H; Hongo M
    Am J Gastroenterol; 2009 May; 104(5):1106-11. PubMed ID: 19337239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD; Lotfi-Emran S
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
    Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of acid-suppressive therapy after the endoscopic diagnosis of reflux esophagitis.
    Boom HD; Loffeld RJ
    Dis Esophagus; 2000; 13(4):271-4. PubMed ID: 11284972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese.
    Hung CS; Lee CL; Yang JN; Liao PT; Tu TC; Chen TK; Wu CH
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1900-5. PubMed ID: 16336451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.